(Q33368240)
Statements
1 reference
Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle (English)
1 reference
1 reference
1 reference
Hamilton AL
1 reference
Eder JP
1 reference
Pavlick AC
1 reference
Clark JW
1 reference
Liebes L
1 reference
Garcia-Carbonero R
1 reference
Chachoua A
1 reference
Ryan DP
1 reference
Soma V
1 reference
Farrell K
1 reference
Kinchla N
1 reference
Boyden J
1 reference
Yee H
1 reference
Wright J
1 reference
Elliott P
1 reference
Adams J
1 reference
1 September 2005
1 reference
1 reference
Identifiers
1 reference